Zelira Therapeutics (ASX: ZLD) secures US$33 million for cannabis autism drug as shares double, but long-term holders remain underwater
Perth-based cannabis company Zelira Therapeutics has locked in US$33 million from a New York investment firm to push its autism medication through U...





















